中国
HEBEI XINGANG PHARMACEUTICAL CO., LTD
会员限时活动
1580
元/年
企业联系人
详细交易记录
实时最新数据
交易概况
总交易额
20,536,262.77
交易次数
65
平均单价
315,942.50
最近交易
2025/05/12
HEBEI XINGANG PHARMACEUTICAL CO., LTD 贸易洞察 (供应商)
过去5年,HEBEI XINGANG PHARMACEUTICAL CO., LTD在中国市场展现出 交易非常活跃,今年已有多笔成交。 总交易额达 20,536,262.77 ,累计 65 笔交易。 平均单价 315,942.50 ,最近一次交易于 2025/05/12。
贸易记录
日期 | 交易公司 | 交易描述 | 数量 | 金额 |
---|---|---|---|---|
2022-08-01 | SCHAZOO ZAKA (PRIVATE) LIMITED | Antibiotics (excl. penicillins and their derivatives with a penicillanic acid structure, salts ... PHARMACEUTICAL RAW MATERIAL FOR THE PHARMACEUTICAL INDUSTRY RIFAMPICIN BP2019 DRAP CEARANCE CERTIFICATE NO E-1431962829516 DT 20-06-2022 | 500.00KG | 86037.67USD |
2025-04-04 | OXALIS LABS | RIFAMPICIN RIFAMPICIN | 1779.33KGS | 293589.44USD |
2023-09-18 | SVIZERA LABS PRIVATE LIMITED | Antibiotics (excl. penicillins and their derivatives with a penicillanic acid structure, salts thereof, streptomycins, tetracyclines, chloramphenicol and erythromycin, their derivatives and salts thereof): Ciprofloxacine and its salts RIFAMPICIN B.P. G... | 2500.00KGS | 426168.03USD |
2023-02-10 | SCHAZOO ZAKA (PRIVATE) LIMITED | Antibiotics (excl. penicillins and their derivatives with a penicillanic acid structure, salts ... PHARMACEUTICAL RAW MATERIAL FOR THE PHARMACEUTICAL INDUSTRY RIFAMPICIN BP2020 DRAP CLEARANCE CERTIFICATE E-4338262822458 DATED 30-01-2023 | 500.00KG | 81344.43USD |
2024-12-24 | SVIZERA LABS PRIVATE LIMITED | RIFAMPICIN I.P./B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31.03.2025)RIFAMPICIN I.P./B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31 | 2000.00KGS | 339183.88USD |
2024-05-14 | MACLEODS PHARMACEUTICALS LTD | RIFAMYCIN S | 2000.00KGS | 189998.94USD |
贸易国家分析
HS编码情报
HS编码 | 产品描述 | 频次 |
---|---|---|
854140 | 光电二极管、晶体管、类似半导体器件 | 42 |
847130 | 便携式数字处理设备 | 35 |
851762 | 无线网络接入设备 | 28 |
847330 | 电子计算机零件 | 22 |
852910 | 天线和天线反射器 | 18 |
853400 | 印刷电路板 | 15 |